AFos dissociates cardiac myocyte hypertrophy and expression of the pathological gene program
about
TrpC3 regulates hypertrophy-associated gene expression without affecting myocyte beating or cell size.AFos inhibits phenylephrine-mediated contractile dysfunction by altering phospholamban phosphorylation.Cross-talk between angiotensin II and IGF-1-induced connexin 43 expression in human saphenous vein smooth muscle cells.Sex differences in cardiomyocyte connexin43 expression.Propranolol causes a paradoxical enhancement of cardiomyocyte foetal gene response to hypertrophic stimuli.Knockout of beta(1)- and beta(2)-adrenoceptors attenuates pressure overload-induced cardiac hypertrophy and fibrosis.MAP kinase kinase kinase-2 (MEKK2) regulates hypertrophic remodeling of the right ventricle in hypoxia-induced pulmonary hypertension.Gallic acid prevents isoproterenol-induced cardiac hypertrophy and fibrosis through regulation of JNK2 signaling and Smad3 binding activity.Involvement of connexin 43 in angiotensin II-induced migration and proliferation of saphenous vein smooth muscle cells via the MAPK-AP-1 signaling pathway.Divergence of hypertrophic growth and fetal gene profile: the influence of beta-blockers.Phenylephrine hypertrophy, Ca2+-ATPase (SERCA2), and Ca2+ signaling in neonatal rat cardiac myocytes.Restoration of CREB function is linked to completion and stabilization of adaptive cardiac hypertrophy in response to exercise.Network-based predictions of in vivo cardiac hypertrophyActivin Receptor-Like Kinase 4 Haplodeficiency Mitigates Arrhythmogenic Atrial Remodeling and Vulnerability to Atrial Fibrillation in Cardiac Pathological Hypertrophy
P2860
Q33295387-24D690D8-AD66-4991-8F91-8FA3C9C26018Q33917067-2AB9CCB4-C7A5-46FC-A01A-14F2DDC18BBBQ34398211-016A3DDD-2B4C-4AE7-A4BE-2DD0BD2AB02EQ35106659-82DE8850-75D5-476E-9A46-8F05DF7C5125Q35995211-F8D746DD-9D94-40FE-BCEB-A114E0EC82CCQ36484609-17194C26-D885-4407-A13B-676F7188AC50Q36528033-8F3928C8-1703-4758-8A77-48C3AD0536B9Q37310859-F07B18F6-D528-4ADD-998B-AB783309D586Q37395007-A486C42D-AF07-48D0-9E26-67A1C0A28A02Q42370598-5B14BD18-3D68-4144-B16B-E95279AAFD4CQ46647997-893B152D-66FF-4547-8FF8-A1E40CB0362FQ51763589-BB77D1B6-B8DD-43C2-B575-E2494B1C8A38Q56335220-83B044E3-8928-4B34-8B32-6706B1A28BAAQ58129769-1E390869-5EAC-4E93-ADC0-3F501680F1B5
P2860
AFos dissociates cardiac myocyte hypertrophy and expression of the pathological gene program
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
AFos dissociates cardiac myocy ...... the pathological gene program
@ast
AFos dissociates cardiac myocy ...... the pathological gene program
@en
type
label
AFos dissociates cardiac myocy ...... the pathological gene program
@ast
AFos dissociates cardiac myocy ...... the pathological gene program
@en
prefLabel
AFos dissociates cardiac myocy ...... the pathological gene program
@ast
AFos dissociates cardiac myocy ...... the pathological gene program
@en
P2093
P2860
P1433
P1476
AFos dissociates cardiac myocy ...... the pathological gene program
@en
P2093
Carlin S Long
Charles Vinson
Koichiro Kinugawa
Mark Y Jeong
P2860
P304
P356
10.1161/01.CIR.0000160367.99928.87
P407
P577
2005-03-28T00:00:00Z